Rising levels of human cytomegalovirus (HCMV) antigenemia during initial antiviral treatment of solid-organ transplant recipients with primary HCMV infection

Journal of Clinical Microbiology

Volumn 36, Issue 4, 1998, Pages 1113-1116

  Gerna, G ^a   Zavattoni, M ^a   Percivalle, E ^a   Grossi, P ^a   Torsellini, M ^a   Revello, M G ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; FOSCARNET; GANCICLOVIR; STEROID; THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIVIRAL ACTIVITY; ARTICLE; CLINICAL ARTICLE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; FEMALE; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; VIREMIA;

EID: 0031944950     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.36.4.1113-1116.1998     Document Type: Article

References (17)